In November 2024 the National Institute for Health and Care Excellence (NICE), in collaboration with the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN), launched their updated guideline: Asthma: diagnosis, monitoring and chronic asthma
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) in order to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 known as ‘Keeping it Simple’.
We have issued pragmatic guidance for the routine and crisis management of patients with asthma and COPD during the UK Covid-19 epidemic.
Very Brief Advice (VBA) is our most practical tool to trigger a quit attempt, with structured behavioural support and medical treatment being the best method of quitting and ideally these are provided by stop smoking practitioners.
Tobacco dependency is a long-term relapsing condition that usually starts in childhood This tobacco dependency pragmatic guide is a practical, immediately implementable, evidence-based framework to enable healthcare professionals to routinely identify smokers, encourage a quit attempt a
Asthma Guidelines in Practice – A PCRS Consensus is a practical and pragmatic guide for healthcare professionals working in primary and intermediate care. This guide was commissioned to provide clarity on aspects of diagnosis, management and monitoring of asthma that are uncertain
This document outlines a consensus recommendation based on the best available evidence and expert opinion. Its purpose is to provide guidance on a safe approach within the limitations of the evidence and devices currently available.
2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.
In November 2024 NICE, in collaboration the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN), released guidance NG245.
The Primary Care Respiratory Society (PCRS) believe that by working together we can achieve more environmentally friendly respiratory healthcare.
Over the past 20-years, there has been an increased focus on the use of newer biologic medication in people with severe asthma that is not controlled with usual asthma medication.
As healthcare professionals, we face the dual challenge of providing high-quality care while also minimising our environmental footprint.
The NHS is under increased financial and environmental pressures. Blanket switching of medications (changing medication from one to another without patient consultation) to more cost-effective and environmentally friendly options is therefore becoming more common.